By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kite Pharma, Inc. 

2225 Colorado Avenue

Santa Monica  California  90404  U.S.A.
Phone: 301-824-9999 Fax: n/a


Company News
Kite Pharma, Inc. Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 6/23/2014 7:38:45 AM
Kite Pharma, Inc. Ups Proposed Deal Size To $120 Million, Raising Price Range To $17 Per Share 6/20/2014 6:20:02 AM
Kite Pharma, Inc. Expands R&D Team, Appoints Dr. William Y. Go As Senior Director, Clinical Development And Jeff Aycock As Senior Director, Clinical Operations 6/11/2014 6:14:28 AM
Kite Pharma, Inc. Announces Exclusive License With The National Institutes of Health (NIH) For T Cell Receptor (TCR)-Based Products Targeting NY-ESO-1 For Multiple Cancer Indications 6/9/2014 8:27:26 AM
Kite Pharma, Inc. Names David Chang, M.D., Ph.D., To Lead R&D Programs 6/2/2014 7:22:24 AM
Kite Pharma, Inc. To Highlight Cancer Immunotherapy T Cell Manufacturing Process At 2014 American Society of Clinical Oncology Annual Meeting 5/30/2014 7:07:14 AM
Santa Monica's Kite Pharma, Inc. Gears Up For IPO Debut 5/20/2014 7:34:19 AM
Kite Pharma, Inc. Appoints Jeffrey S. Wiezorek, M.D., M.S., As Vice President, Clinical Development 5/12/2014 6:41:51 AM
Kite Pharma, Inc. Reels In $50 Million Private Financing 4/28/2014 6:37:14 AM
Kite Pharma, Inc. Expands Leadership Team And Announces Senior Management Promotions 4/14/2014 6:20:27 AM